KQB198
/ Kumquat Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 17, 2024
A Study to Investigate the Safety and Efficacy of KQB198 As Monotherapy and in Combination in Participants with Advanced Hematologic Malignancies
(clinicaltrials.gov)
- P1 | N=122 | Recruiting | Sponsor: Kumquat Biosciences Inc.
Combination therapy • Metastases • Monotherapy • New P1 trial • Hematological Disorders • Hematological Malignancies • Oncology • ABL1 • BCR
July 18, 2024
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
(clinicaltrials.gov)
- P1 | N=100 | Recruiting | Sponsor: Kumquat Biosciences Inc.
Combination therapy • Metastases • Monotherapy • New P1 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1